Sterilization Technology Industry was Led by the North American Region

The sterilization technology market will touch a value of USD 17,313.7 million by 2030, powering at a rate of 7.1% in the years to come, as stated by P&S Intelligence.

To learn more about this report: https://bit.ly/3XcK7s6

China is experiencing advance in the industry because of its booming pharma sector, growing prevalence of chronic ailments, aging populace, growing air pollution levels, and promising regulations of the government. 

As per the ITA, China is the second largest pharma market globally, and it will grow even further in the years to come.

The industry is powered by the increasing occurrence of HAIs, growing surgery count, and rising requirement for sterile pharma products.

North America was the leader of the pack in the sterilization technology market, with a share of more than over 40% in the past. 

The development in the regional market is because of the increasing R&D activities of pharma companies, growing healthcare spending, thriving geriatric population, increasing hospital count, and mounting cases of nosocomial infections.

Furthermore, because of the growing prevalence of chronic ailments, healthcare providers are determined to offer sterile environments to patients, for avoiding any other risk of catching an infection.

With the increasing cases of HAI all over the world, the demand for sterilization technology will continue to increase even further by the end of this decade.

Read More

Hospital Acquired Infection Control Industry Will Grow Fastest in Asia-Pacific

The hospital-acquired infection control market will touch USD 34,909.7 million by 2030, driven at a rate of 1.6%. The industry advance will be powered by the growing count of surgical procedures, increasing consciousness of environmental and personal hygiene, and rising chronic disease prevalence.

To learn more about this report: https://bit.ly/3WKNhmN

All patients who are hospitalized are vulnerable to contracting a nosocomial infection. Young children, the aged, and people with a weak immune system are more vulnerable to HAIs than others.

Thus, disinfection is a popular procedure, with an over 68% market share in the past, with hospitals trying to lower the rates of HAIs. HAI symptoms can appear in two–three days after a patient's hospital admission and continue for up to 10 days post discharge. For preventing these infections, the acceptance of disinfection is on the rise. Some widely used disinfectants for preventing the spread of nosocomial infections are glutaraldehyde, formaldehyde, and hydrogen peroxide.

Recently, a drastic rise in the occurrence of neurological ailments, traumatic wounds, and CVDs and the introduction of cutting-edge surgical technologies, to manage and treat them, have been observed. As a result of these events, HAI control product demand is witnessing growth. For example, people suffering from neurological infections or accidents every year number nearly 20 million, approximately 14 million of whom need surgery.

Therefore, north America dominated the hospital-acquired infection control market, with a 35% revenue share, as stated by P&S Intelligence. This is because of the increase in the elderly population, the surge in the incidence of chronic diseases and HAIs, and the existence of prominent market players. For example, in the U.S., the population of people more than 65 years is nearly 45 million, and this number will reach more than 80 million by 2050.

Furthermore, the incidence of HAIs in the continent is extremely high. At hospitals in the U.S., the incidence of HAIs is above 1.5 million, and 100,000 people die of them each year.

APAC will grow the fastest in the years to come. In developing and underdeveloped nations, the requirement for HAI control solutions is on the rise on account of the increasing count of patients and economic development.

Moreover, the acceptance of cutting-edge medical equipment is snowballing with the augmentation in governments’ spending on healthcare sector, which is primarily being seen in a rise in the count of community, primary-care, secondary-care, and tertiary-care medical centers. Further, these nations lack the resources and awareness required to control HAIs, which makes the region a key opportunity area for market players.

It is because of the increasing number of surgical procedures that the demand for hospital-acquired infection control will increase even further in the years to come.

Read More

NGS Sample Preparation Industry Was Led by North America

The NGS sample preparation market will reach to USD 5,501.2 million by 2030, powering at a rate of 14.7% in the years to come. This is because of the tech-progressions in NGS platforms, the increase in the occurrence of genetic ailments, and the rise in requirement for direct-to-consumer genetic testing, as stated by P&S Intelligence.

To learn more about this report: https://bit.ly/45CYytq

Furthermore, the increasing incidence of communicable diseases also improves the growth of the industry.

The consumables category had the largest share, of  more than 50% in the past, and it will be like this in the years to come. The high share of consumables is credited to the growing requirement for testing and related components and equipment, along with increasing applicable research in RNA, DNA, and whole genome sequencing.

North America led the NGS sample preparation market, and it will grow significantly, at a rate of around 15%. This has a lot to do with the high acceptance rate of sequencing technologies and NGS sample preparation sequencing solutions.

Also, the surge in the count of NGS-based research and clinical uses and the auspicious initiatives taken by the private  and government bodies for the growth and acceptance of NGS technologies help drive the industry.

APAC will grow the fastest in the future. This can be credited to the surge in medical research, heightened consciousness of these solutions, and the existence of protruding service providers.

It is because of the growth for D2C genetic testing industry, the demand for NGS sample preparation will continue to grow in the future.

Read More

Bio Decontamination Industry Is Dominated by North America

As mentioned by P&S Intelligence, in one of its reports, the total size of the bio decontamination market was USD 171.4 million in 2022, and it will reach USD 294.7 million by 2030, powering at a CAGR of 7% by the end of this decade.

Get the sample pages of this report: https://bit.ly/43uQqJM

Equipment category dominated the industry, with around 55% share, in the recent past. This has a lot to do with the presence of numerous equipment and benefits related to them.

The equipment should be clean and have a surface free of any debris when steam sterilization is to be done, so that the sterilant can interact with all instrument surfaces.

Furthermore, sterilizers  have a porous load that makes use of steam for sterilizing instruments. This makes it likely to hold the steam machine in straight contact with the substances for a while. 

In its place, improved disinfection, which is usually credited to the washer action, this equipment delivers complete sterilization. These sterilizers need a vacuum for the steam for reaching all surfaces of any products having holes or interior areas.

Hydrogen Peroxide lead the industry, with over 40%, in the recent past. Low amount of hydrogen peroxide vapor is an efficient decontaminant for numerous bacteria. VHP might not only penetrate a lot of materials but also remove germs found in joints and seams. A vapor can efficiently enter these locations by permeating them. Plastic membranes can likewise be pierced by hydrogen peroxide vapor.

North America dominated the bio decontamination market with a share of 45%.  This has a lot to do with various factors, for example increasing HAIs frequency and surgical processes and incidence of major players. The main reason for augmented surgical procedures is growing incidence of cancer. In the U.S., and Canada cancer is the second-leading mortality cause, behind heart disease.

While lung cancer is the most dominant cause of cancer death in men and women, breast and prostate cancer are the most detected in both sexes.

Due to risky behaviors being predominant in Canada and the U.S., patterns of occurrence of cancer are similar in both the nations. Cancers associated with infections have a low frequency but cancers associated with changing of lifestyle have a high incidence. For example, colorectal cancer is the most happening in the continent. However, there is substantial regional and socioeconomic heterogeneity in incidence and mortality in North America because this cancer is mostly avoidable and treatable.

It is because of the increased incidence of hospital acquired infection and growing number of surgical procedures, the bio contamination industry will develop like anything  in the years to come, all over the world.

Read More

The Future of Endodontic Devices

As per a market research report by P&S Intelligence, the endodontic devices industry was USD 1,492.0 million in 2021, and it will power at a compound annual growth rate of 4.8% in the years to come, to reach USD 2,283.4 million by 2030.

To learn more about this report: https://bit.ly/3Mf892t

Instruments leads the industry, and it will generate a revenue of USD 1,206.7 million in 2030, as a result of the expansions in delivery systems, which have provided multiple benefits to dentists, for example ease of treatment and maneuvering of handpieces throughout surgeries. 

These delivery systems are now obtainable as over-the-head, side, rear, and over the-patient alternatives. Over-the-patient systems license free movement of patient’s head throughout operations, therefore allowing their easy steering for an enhanced field vision.

North America endodontic devices market dominated the scene, and will generate a revenue of USD 898 million in 2030, at a rate of 4.6% in the years to come. 

Some key factors powering this growth are the increasing population, snowballing investments in dentistry research and developments, rising preference for root canal treatments over implants, and propagation of experts and dental clinics.

It is because of the rise in dental tourism, the demand for endodontic devices will be considerably on the rise in the years to come.

Read More

How Does Cancer Drug Discovery Impact Microarray Analysis Industry?

The microarray analysis industry contributes revenue worth $3,846.7 million in 2021, and it is projected to rise at a rate of 9.9% in the coming future, to generate $9,011.1 million in revenue in 2030. 

It is ascribed to the rising application area of microarrays, growing cancer prevalence, and government initiatives for proteomic and genomic research. Microarray analysis is highly utilized in pharmaceutical screening, toxicology screening, and biomarker identification to understand DNA mutation. In addition, microarray facilitates the screening of various genes in real-time.

To learn more about this report: https://bit.ly/3lyrUH3

Moreover, North America holds a significant share of the microarray analysis industry, accounting for 40%, and it is projected to experience extensive growth in the near future, leading to increased funding from Canada and the U.S. governments for cancer research.

Under the project and category segment, consumables are expected to experience significant growth of around 10% from 2021 to 2030, led by the rising number of research institutes and diagnostic laboratories that use microarray analysis. In addition, the rising research on mRNA and DNA methylation boosts the demand for consumables to carry out microarray analyses.

In addition, software and services capture the third-largest share of the microarray analysis industry, attributed to the wide usage of the software for identifying and analyzing genomes by utilizing data for the study. Similarly, the rising number of experiments boosts the advanced services and tools adoption for carrying out studies.

DNA microarrays capture a substantial share of the industry, and it is projected to experience a growth rate of 10% in the coming years, owing to the DNA microarray's usage in clinical diagnostic tests for various diseases. Moreover, they are also utilized for determining which medicine is the best prescription for a specific patient, as these genes identify how the body manages the drug chemistry.

In addition, DNA microarrays are primarily used for mutation identification in the genetic structure. The short-single stranded DNAs of genetic disorders are produced and combined with patients' DNA for analysis. The synthetic binding of DNA with the produced DNA, and coherent material facilitates the identification of mutation type of cancer. Therefore, the growing prevalence of cancer is the primary contributor to the rising demand for DNA microarrays.

The research and academic institutes capture an extensive share of the microarray analysis industry, and they are projected to contribute to the sales worth $4.0 billion of the associate products in 2030. Over the years, there has been a significant rise in human genome study projects. Microarrays are utilized for cancer drug discovery. Therefore, the rise in research and development investments in the healthcare sector is projected to boost industry growth.

Moreover, the pharmaceutical and biotechnology companies are projected to experience rapid growth in the industry, ascribed to various research programs conducted for drug development.

In addition, Europe is the next-significant contributor after North America, attributed to the highly developed healthcare industry of the region, with advanced R&D infrastructure, and ease of access to the associated products. Cancer detection supported by point-of-care testing in Europe drives the industry growth.

Therefore, the rising investments in research and development in the healthcare sector are projected to boost industry growth. 

Read More